JD
Therapeutic Areas
Salubris Biotherapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Cardiovascular Program(s) | Cardiovascular Disease | Clinical-stage (phase unspecified) |
| Undisclosed Oncology Program(s) | Oncology | Clinical-stage (phase unspecified) |
Leadership Team at Salubris Biotherapeutics
SM
Sam Murphy
Chief Executive Officer
SS
Shalabh Singhal
Chief Medical Officer
SD
Stephen DiPalma
Interim Chief Financial Officer